Nanchangamycin

An ionophore antibiotic.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Natural product

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Nanchangamycin is a bacteria-derived natural substance with anti-Zika virus properties (Rausch et al., 2017).

Link	Tested on	Impact factor	Notes	Publication date
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro Small molecule In vitro	Vero E6 cells; Vero E6-hTMPRSS2 cells; Calu-3 cells	4.10	Inhibited SARS-CoV-2 in cell culture.	Nov/25/2020